Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study
In: Transplant Infectious Disease, Jg. 19 (2017-05-09), S. e12694
Online
unknown
Zugriff:
Background The optimal length of cytomegalovirus (CMV) prophylaxis in lung transplantation according to CMV serostatus is not well established. Methods We have performed a prospective, observational, multicenter study to determine the incidence of CMV infection and disease in 92 CMV-seropositive lung transplant recipients (LTR), their related outcomes and risk factors, and the impact of prophylaxis length. Results At 18 months post transplantation, 37 patients (40%) developed CMV infection (23 [25%]) or disease (14 [15.2%]). Overall mortality was higher in patients with CMV disease (64.3% vs 10.2%; P
| Titel: |
Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study
|
|---|---|
| Autor/in / Beteiligte Person: | Monforte, Víctor ; Cifrián, José M. ; Sintes, Helena ; Zurbano, Felipe ; Borro, José M. ; López-Gallo, Cristina ; Ussetti, Piedad ; Santos, Francisco ; Delgado, Maria ; Roman, Antonio ; Redel-Montero, Javier ; Gavaldà, Joan ; Solé, Amparo ; Pastor, Amparo |
| Link: | |
| Zeitschrift: | Transplant Infectious Disease, Jg. 19 (2017-05-09), S. e12694 |
| Veröffentlichung: | Wiley, 2017 |
| Medientyp: | unknown |
| ISSN: | 1398-2273 (print) |
| DOI: | 10.1111/tid.12694 |
| Schlagwort: |
|
| Sonstiges: |
|